Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles

Hypersplenism associated with cirrhotic portal hypertension is a common condition often resulting from hepatitis B-related cirrhosis. However, the levels of immunoglobulin (Ig) and complement in patients with hypersplenism associated with cirrhotic portal hypertension remain unclear. This study was...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of clinical cases Vol. 10; no. 36; pp. 13208 - 13215
Main Authors Zhang, Kun, Zeng, Min, Li, Ye-Juan, Wu, Hong-Fei, Wu, Jin-Cai, Zhang, Zhen-Sheng, Zheng, Jin-Fang, Lv, Yun-Fu
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 26.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hypersplenism associated with cirrhotic portal hypertension is a common condition often resulting from hepatitis B-related cirrhosis. However, the levels of immunoglobulin (Ig) and complement in patients with hypersplenism associated with cirrhotic portal hypertension remain unclear. This study was undertaken to determine the levels of Ig and complement in these patients, the relationship between these levels and Child-Pugh class and their clinical significance. To investigate the antibody (Ig) and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and their clinical significance. Clinical data of 119 patients with hypersplenism associated with cirrhotic portal hypertension were statistically analyzed and compared with those of 128 control patients. IgA and IgG levels in patients with hypersplenism were significantly higher than controls ( < 0.001). There was no significant difference in IgM between the two groups ( = 0.109). C3 and C4 levels in patients with hypersplenism were significantly lower than controls ( < 0.001). As liver function decreased, IgA and IgG levels increased ( < 0.001), and C3 and C4 levels decreased ( < 0.001). Patients with hypersplenism associated with cirrhotic portal hypertension have significantly higher antibody (IgA and IgG) levels and significantly lower complement (C3 and C4) levels, which are both related to liver damage. Clinically, the administration of anti-hepatitis virus agents and protection of liver function should be strengthened.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Zhang K, Zeng M, Li YJ, Wu JC, Zheng JF and Lv YF contributed equally to this work; Lv YF was responsible for project design and thesis writing; Zhang K and Li YJ were responsible for implementation and statistical information; Wu JC, Zheng JF and Zeng M were responsible for data and statistical information collection; Wu HF and Zhang ZS participated in data collection and registration; all authors have read this article and consent to publication.
Supported by Hainan Provincial Department of Science and Technology, Qiongke[2020]256.
Corresponding author: Yun-Fu Lv, Doctor, MD, PhD, Academic Research, Chief Doctor, Professor, Research Scientist, Surgeon, Department of General Surgery, Hainan General Hospital, No. 19 Xiuhua Road, Xiuyin District, Haikou 570311, Hainan Province, China. yunfu_lv@126.com
ISSN:2307-8960
2307-8960
DOI:10.12998/wjcc.v10.i36.13208